knowledge -WSS

knowledge

author：comprehensive 2025-09-30 16:29:22 - browse：46414

Dolly sheep — Alex Hogan/STAT, Getty Images

Dolly, the first animal to be cloned from an adult of its species, was born 20 years ago today at the Roslin Institute in Scotland. When her creators announced what they had done, it triggered warnings of rich people cloning themselves for spare parts, of tyrants cloning soldiers for armies, of bereaved parents cloning their dead child to produce a replacement — and promises that the technique would bring medical breakthroughs. Which raises some questions:

Why are there no human clones?

Because of scientific, ethical, and commercial reasons.

The scientists who created Dolly — named after Dolly Parton, naturally — removed the DNA from a sheep ovum, fused the ovum with a mammary epithelial cell from an adult “donor” sheep, and transplanted the result, now carrying DNA only from the donor, into a surrogate ewe. But that technique, called somatic cell nuclear transfer (SCNT), turned out not to be so easy in other species.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： A common UTI test for kids haunts adults as a traumatic 'nightmare'

WSS

White House touts steps to stem shortages of cancer treatments

Long Covid needs a new name — and a new frame

What drug price negotiations mean for Medicare Part D

What drug price negotiations mean for Medicare Part D

The (many) problems with a new study criticizing cancer screening

Snackable artificial intelligence, expert AI, and the pharma industry

explore

knowledge

Why are there no human clones?

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

How to fix cancer clinical trials' diversity problem

Medicare details structure of new drug price negotiation program

Pig kidney works a record two months in donated body

The high cost of giving birth even with insurance

Regeneron agrees to White House price limits on anti

Drug repurposing or repositioning? The language matters

What American doctors can learn from their Israeli counterparts

FDA approval of Sarepta Duchenne genetic therapy gives me hope

New Covid vaccine is recommended for everyone 6 months or older

leisure time

Telehealth for opioid use disorder is lifesaving

The 10 drugs up first for Medicare price negotiation

FDA panel endorses Alnylam’s heart drug — after picking it apart

Snackable artificial intelligence, expert AI, and the pharma industry

Regeneron agrees to White House price limits on anti

Acelyrin, a rare IPO success, stumbles in its first big test

explore

explore

hotspot

entertainment